CIRM Funded Clinical Trials

Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant

Disease Area: 
Anemia
Bone Marrow Transplant and Viral Infection
Investigator:
CIRM Grant:
CLIN2-14024 (Pre-Active)
Award Value:
$11,998,188
Trial Sponsor:
Stanford University
Trial Stage: 
Phase 1/2
Trial Status: 
Launching
Targeted Enrollment:
N/A